 Treatment for Hyperphosphatemia to Generate a Value Pool exceeding US 20 Billion by 2033; Iron-based Phosphate Binders to account for 20 of Total Demand. Market share for hyperphosphatemia in Asia Pacific is forecast to reach 32 by 2033. DUBAI, United Arab Emirates, Jan. 10, 2023 GLOBE NEWSWIRE Future Market Insights estimates that the Hyperphosphatemia ... The post The Hyperphosphatemia Market is Expected to Reach US 20.44 Billion and to expand at a CAGR of 4.8 through 2033 Future Ma... 